An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani

Nucleic Acids Research

Volumn 30, Issue 3, 2002, Pages 794-802

  Das, Aditi ^a   Mandal, Chhabinath ^a   Dasgupta, Arindam ^a   Sengupta, Tanushri ^a   Majumder, Hemanta K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA; DNA TOPOISOMERASE; GENE PRODUCT; OLIGONUCLEOTIDE; RECOMBINASE; SERINE; TYROSINE;

CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA BINDING; DNA STRAND; DNA TEMPLATE; ENZYME ACTIVE SITE; ENZYME STRUCTURE; FLAGELLATE; GENE CONVERSION; LEISHMANIA DONOVANI; MOLECULAR MODEL; NONHUMAN; NUCLEIC ACID METABOLISM; OPEN READING FRAME; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY;

KINETOPLASTIDA; LEISHMANIA DONOVANI; MASTIGOPHORA (FLAGELLATES); PROTOZOA;

EID: 0036464504     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/30.3.794     Document Type: Review

References (37)

1. Mechanistic aspects of type-I topoisomerases
2. DNA topoisomerases
3. Three-dimensional structure of the 67 kD N-terminal fragment of E. coli DNA topoisomerase I
4. Solution structure of the C-terminal single-stranded DNA-binding domain of Escherichia coli topoisomerase I
5. A 26 kDa yeast DNA topoisomerase I fragment: Crystallographic structure and mechanistic implications
6. Crystal structure of the N-terminal fragment of vaccinia virus DNA topoisomerase I
7. Crystal structure of human topoisomerase I in covalent and noncovalent complexes with DNA
8. A model for the mechanism of human topoisomerase I
9. Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures
10. Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases
11. Structural insights into the function of type IB topoisomerases
12. DNA topoisomerases as anticancer drug targets
13. DNA topoisomerases as targets of therapeutics: An overview
14. Inhibition of topoisomerases in African trypanosomes
15. Characterization of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase
16. A type 1 DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani
17. Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognised inhibitor of topoisomerase I from Leishmania donovani
18. Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines
19. Diospyrin, a bisnapthoquinone; a novel inhibitor of type 1 DNA topoisomerase of Leishmania donovani
20. Purification and characterization of the DNA untwisting enzyme from rat liver
21. Covalent bonds between protein and DNA
22. ABGEN: A knowledge based automated approach for antibody structure modeling
23. MOLMOL: A program for display and analysis of macromolecular structures
24. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
25. TREEVIEW: An application to display phylogenetic trees on personal computers
26. Camptothecin induced protein-linked DNA breaks via mammalian DNA topoisomerase I
27. Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I
28. cDNA cloning of human DNA topoisomerase I: Catalytic activity of a 67.7 kDa C-terminal fragment
29. Topoisomerase I has a strong binding preference for a conserved hexadecameric sequence in the promoter region of the rRNA gene from Tetrahymena pyriformis
30. Topoisomerase I has a strong binding preference for a conserved hexadecameric sequence in the promoter region of the rRNA gene from Tetrahymena pyriformis
31. DNA topoisomerases: Structure, function and mechanism Annu
32. Molecular modelling studies of the DNA topoisomerase I ternary cleavable complex with camptothecin
33. A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA and camptothecin
34. Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases
35. Flexibility in DNA recombination: Structure of the λ integrase catalytic core
36. Crystal structure of the site-specific recombinase γδ resolvase complexed with a 34 bp cleavage site